Revance Therapeutics, Inc.
NASDAQ:RVNC
5.85 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 137.879 | 108.965 | 110.623 | 333.558 | 171.16 | 73.256 | 282.896 | 63.502 | 201.615 | 171.032 | 3.914 | 4.083 | 29.621 |
| Short Term Investments
| 116.586 | 231.742 | 114.448 | 102.947 | 118.955 | 102.556 | 0 | 122.026 | 50.688 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 254.465 | 340.707 | 225.071 | 436.505 | 290.115 | 175.812 | 282.896 | 185.528 | 252.303 | 171.032 | 3.914 | 4.083 | 29.621 |
| Net Receivables
| 27.676 | 11.339 | 3.348 | 1.829 | 0 | 27 | 0.048 | 6.026 | 0.158 | 0.3 | 0.225 | 0.075 | 0 |
| Inventory
| 45.579 | 18.325 | 10.154 | 5.876 | 0 | 0 | 0 | 0.978 | 1.235 | 1.16 | 0.606 | 1.172 | 0 |
| Other Current Assets
| 11.145 | 4.356 | 7.544 | 5.793 | 6.487 | 5.11 | 2.267 | 0.163 | 0.267 | 0.239 | 0.069 | 0.075 | 0.01 |
| Total Current Assets
| 338.865 | 374.727 | 246.117 | 450.003 | 296.602 | 207.922 | 285.211 | 192.695 | 253.963 | 172.731 | 4.814 | 5.405 | 30.119 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 90.207 | 67.755 | 69.001 | 47.131 | 41.286 | 14.449 | 9.25 | 10.585 | 19.708 | 19.274 | 14.315 | 6.98 | 8.439 |
| Goodwill
| 0 | 77.175 | 146.964 | 146.964 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 9.808 | 27.004 | 55.334 | 71.343 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 9.808 | 104.179 | 202.298 | 218.307 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 6.87 | 6.052 | 5.046 | 3.445 | 0.73 | 0.73 | 0.58 | 0.58 | 1.751 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | -6.052 | -5.046 | -3.445 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 32.704 | 35.239 | 13.747 | 4.779 | 1.669 | 3.247 | 0.658 | 0.5 | 0.4 | 0.464 | 3.516 | 1.038 | 1.37 |
| Total Non-Current Assets
| 139.589 | 207.173 | 285.046 | 270.217 | 43.685 | 18.426 | 10.488 | 11.665 | 21.859 | 19.738 | 17.831 | 8.018 | 9.809 |
| Total Assets
| 478.454 | 581.9 | 531.163 | 720.22 | 340.287 | 226.348 | 295.699 | 204.36 | 275.822 | 192.469 | 22.645 | 13.423 | 39.928 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 13.809 | 4.546 | 10.603 | 12.657 | 8.01 | 8.434 | 6.805 | 3.754 | 2.657 | 3.149 | 5.526 | 1.805 | 0.777 |
| Short Term Debt
| 10.854 | 4.912 | 4.746 | 4.437 | 3.47 | 14.407 | 1.872 | 3.475 | 3.135 | 2.942 | 22.864 | 95.449 | 4.551 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 10.737 | 6.867 | 9.362 | 7.851 | 7.911 | 8.588 | 11.515 | 11.757 | 5.547 | 3.697 | 0.083 | 5.564 | 0.5 |
| Other Current Liabilities
| 53.824 | 59.357 | 42.578 | 36.019 | 21.588 | 0.541 | 0.71 | 0.661 | 0.698 | 0.448 | 19.088 | 15.117 | 3.027 |
| Total Current Liabilities
| 89.224 | 75.682 | 67.289 | 60.964 | 40.979 | 31.97 | 20.902 | 19.647 | 12.037 | 10.236 | 47.561 | 117.935 | 8.855 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 426.595 | 413.556 | 319.766 | 207.672 | 25.87 | 0 | 0 | 1.872 | 5.346 | 0.598 | 2.632 | 11 | 64.436 |
| Deferred Revenue Non-Current
| 70.419 | 78.577 | 74.152 | 77.294 | 47.948 | 42.684 | 0 | 0 | 3.773 | 0 | 0 | 0 | 10 |
| Deferred Tax Liabilities Non-Current
| 40.985 | 0 | 0 | 180.526 | -47.948 | 0 | 0 | 0 | -3.773 | 0 | 0 | 0 | -0.944 |
| Other Non-Current Liabilities
| 2.835 | 1.485 | 1.485 | -180.526 | 47.948 | 6.072 | 5.952 | 5.77 | 5.187 | 5.266 | 130.001 | 101.215 | 113.063 |
| Total Non-Current Liabilities
| 540.834 | 493.618 | 395.403 | 284.966 | 73.818 | 48.756 | 5.952 | 7.642 | 10.533 | 5.864 | 132.633 | 112.215 | 186.555 |
| Total Liabilities
| 630.058 | 569.3 | 462.692 | 345.93 | 114.797 | 80.726 | 26.854 | 27.289 | 22.57 | 16.1 | 180.194 | 230.15 | 195.41 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192.469 | 1.233 | 95.784 | 0 |
| Common Stock
| 0.088 | 0.082 | 0.072 | 0.069 | 0.052 | 0.037 | 0.037 | 0.029 | 0.028 | 0.024 | 3.358 | 0 | 0 |
| Retained Earnings
| -2,078.36 | -1,754.374 | -1,397.952 | -1,126.293 | -844.204 | -684.775 | -542.167 | -421.543 | -332.273 | -258.797 | -195.88 | -218.326 | -160.067 |
| Accumulated Other Comprehensive Income/Loss
| 0.014 | -0.374 | -0.018 | 0 | 0.003 | -0.008 | -13.531 | -0.045 | -0.04 | -9.906 | -8.189 | -6.355 | -4.603 |
| Other Total Stockholders Equity
| 1,926.654 | 1,767.266 | 1,466.369 | 1,500.514 | 1,069.639 | 830.368 | 824.506 | 598.63 | 585.537 | 252.579 | 41.929 | -87.83 | 9.188 |
| Total Shareholders Equity
| -151.604 | 12.6 | 68.471 | 374.29 | 225.49 | 145.622 | 268.845 | 177.071 | 253.252 | 176.369 | -157.549 | -216.727 | -155.482 |
| Total Equity
| -151.604 | 12.6 | 68.471 | 374.29 | 225.49 | 145.622 | 268.845 | 177.071 | 253.252 | 176.369 | -157.549 | -216.727 | -155.482 |
| Total Liabilities & Shareholders Equity
| 478.454 | 581.9 | 531.163 | 720.22 | 340.287 | 226.348 | 295.699 | 204.36 | 275.822 | 192.469 | 22.645 | 13.423 | 39.928 |